BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

531569

SANJIVIN

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SANJIVANI PARANTERAL LTD. Share Price Update

As of the latest trading session, SANJIVANI PARANTERAL LTD. share price is currently at ₹ 228.95, which is up by ₹ 9.05 from its previous closing. Today, the stock has fluctuated between ₹ 216.10 and ₹ 230.00. Over the past year, SANJIVANI PARANTERAL LTD. has achieved a return of -30.41 %. In the last month alone, the return has been -12.87 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SANJIVANI PARANTERAL LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    281.20

  • P/E Ratio (TTM)

    33.27

  • Beta

    0.84

  • Book Value / share

    34.25

  • Return on equity

    10.15%

  • EPS (TTM)

    6.61

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    1.73

info icon alternate text

SANJIVANI PARANTERAL LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 17.89
Operating Expense 15.63
Net Profit 1.73
Net Profit Margin (%) 9.67
Earnings Per Share (EPS) 1.46
EBITDA 2.68
Effective Tax Rate (%) 24.78
Particulars MAR 2025 (Values in Cr)
Revenue 18.18
Operating Expense 15.94
Net Profit 2.19
Net Profit Margin (%) 12.04
Earnings Per Share (EPS) 1.84
EBITDA 3.04
Effective Tax Rate (%) 17.66
Particulars DEC 2024 (Values in Cr)
Revenue 17.35
Operating Expense 15.15
Net Profit 1.90
Net Profit Margin (%) 10.95
Earnings Per Share (EPS) 1.62
EBITDA 2.86
Effective Tax Rate (%) 24.30
Particulars SEP 2024 (Values in Cr)
Revenue 18.13
Operating Expense 15.60
Net Profit 2.30
Net Profit Margin (%) 12.68
Earnings Per Share (EPS) 1.96
EBITDA 3.25
Effective Tax Rate (%) 21.23
Particulars JUN 2024 (Values in Cr)
Revenue 16.44
Operating Expense 14.25
Net Profit 1.71
Net Profit Margin (%) 10.40
Earnings Per Share (EPS) 1.47
EBITDA 2.42
Effective Tax Rate (%) 24.66
Particulars MAR 2025 (Values in Cr)
Revenue 70.10
Operating Expense 60.95
Net Profit 8.10
Net Profit Margin (%) 11.55
Earnings Per Share (EPS) 6.89
EBITDA 11.56
Effective Tax Rate (%) 21.81
Particulars MAR 2024 (Values in Cr)
Revenue 54.41
Operating Expense 47.35
Net Profit 6.17
Net Profit Margin (%) 11.33
Earnings Per Share (EPS) 5.28
EBITDA 8.75
Effective Tax Rate (%) 18.62
Particulars MAR 2023 (Values in Cr)
Revenue 35.49
Operating Expense 31.09
Net Profit 4.51
Net Profit Margin (%) 12.70
Earnings Per Share (EPS) 4.51
EBITDA 6.19
Effective Tax Rate (%) 8.70
Particulars MAR 2022 (Values in Cr)
Revenue 30.61
Operating Expense 25.97
Net Profit 4.85
Net Profit Margin (%) 15.84
Earnings Per Share (EPS) 4.85
EBITDA 5.97
Effective Tax Rate (%) 0.61
Particulars MAR 2021 (Values in Cr)
Revenue 25.10
Operating Expense 23.95
Net Profit 1.42
Net Profit Margin (%) 5.65
Earnings Per Share (EPS) 1.67
EBITDA 2.40
Effective Tax Rate (%) -0.70
Particulars MAR 2025 (Values in Cr)
Book Value / Share 30.83
ROE % 10.14
ROCE % 12.91
Total Debt to Total Equity 0.14
EBITDA Margin 16.49
Particulars MAR 2024 (Values in Cr)
Book Value / Share 22.14
ROE % 7.83
ROCE % 9.77
Total Debt to Total Equity 0.03
EBITDA Margin 16.08
Particulars MAR 2025 (Values in Cr)
Book Value / Share 30.84
ROE % 10.15
ROCE % 13.11
Total Debt to Total Equity 0.10
EBITDA Margin 16.50
Particulars MAR 2024 (Values in Cr)
Book Value / Share 22.14
ROE % 9.29
ROCE % 11.43
Total Debt to Total Equity 0.14
EBITDA Margin 16.08
Particulars MAR 2023 (Values in Cr)
Book Value / Share -3.07
ROE % 8.35
ROCE % 9.05
Total Debt to Total Equity 0.00
EBITDA Margin 14.93
Particulars MAR 2022 (Values in Cr)
Book Value / Share -7.58
ROE % 12.85
ROCE % 7.94
Total Debt to Total Equity 0.00
EBITDA Margin 19.50
Particulars MAR 2021 (Values in Cr)
Book Value / Share -52.83
ROE % -10.37
ROCE % 4.51
Total Debt to Total Equity 0.00
EBITDA Margin 9.56
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.41
Total Assets 78.19
Total Liabilities 78.19
Total Equity 39.87
Share Outstanding 11881694
Price to Book Ratio 7.77
Return on Assets (%) 10.35
Return on Capital (%) 16.86
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 9.56
Total Assets 43.40
Total Liabilities 43.40
Total Equity 27.89
Share Outstanding 11684300
Price to Book Ratio 6.78
Return on Assets (%) 14.20
Return on Capital (%) 21.36
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.56
Total Assets 64.99
Total Liabilities 64.99
Total Equity 38.00
Share Outstanding 11881694
Price to Book Ratio 7.77
Return on Assets (%) 12.46
Return on Capital (%) 18.57
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 9.56
Total Assets 43.40
Total Liabilities 43.40
Total Equity 27.89
Share Outstanding 11684300
Price to Book Ratio 6.78
Return on Assets (%) 14.20
Return on Capital (%) 21.36
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.30
Total Assets 21.00
Total Liabilities 21.00
Total Equity -3.07
Share Outstanding 9998300
Price to Book Ratio -13.50
Return on Assets (%) 21.47
Return on Capital (%) -781.08
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.33
Total Assets 18.29
Total Liabilities 18.29
Total Equity -7.58
Share Outstanding 9998300
Price to Book Ratio -8.64
Return on Assets (%) 26.48
Return on Capital (%) -304.94
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.17
Total Assets 19.27
Total Liabilities 19.27
Total Equity -44.89
Share Outstanding 8498300
Price to Book Ratio -0.21
Return on Assets (%) 7.36
Return on Capital (%) -47.46
Particulars MAR 2025 (Values in Cr)
Net Income 10.35
Cash from Operations 13.72
Cash from Investing -21.91
Cash from Financing 10.45
Net change in Cash 0.94
Free Cash Flow 44.07
Particulars MAR 2024 (Values in Cr)
Net Income 7.57
Cash from Operations -9.58
Cash from Investing -12.21
Cash from Financing 23.15
Net change in Cash 0.23
Free Cash Flow -6.28
Particulars MAR 2025 (Values in Cr)
Net Income 10.35
Cash from Operations 1.08
Cash from Investing -5.80
Cash from Financing 6.13
Net change in Cash 0.09
Free Cash Flow 12.32
Particulars MAR 2024 (Values in Cr)
Net Income 7.57
Cash from Operations -9.58
Cash from Investing -12.21
Cash from Financing 23.15
Net change in Cash 0.23
Free Cash Flow -6.28
Particulars MAR 2023 (Values in Cr)
Net Income 4.94
Cash from Operations 4.72
Cash from Investing -0.99
Cash from Financing -3.73
Net change in Cash -0.03
Free Cash Flow 5.82
Particulars MAR 2022 (Values in Cr)
Net Income 4.87
Cash from Operations 8.56
Cash from Investing -0.67
Cash from Financing -7.68
Net change in Cash 0.16
Free Cash Flow 9.25
Particulars MAR 2021 (Values in Cr)
Net Income 1.41
Cash from Operations 0.61
Cash from Investing -0.41
Cash from Financing -0.25
Net change in Cash -0.09
Free Cash Flow 1.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.42 13.23 1.77 248.45 30.00 / 68.00
BLISS GVS PHARMA LTD 153.00 15.15 1.53 1615.83 105.05 / 190.65
CIPLA LTD 1513.85 22.68 3.92 122283.61 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 324.45 9.14 2.63 954.89 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.42 17.62 5.12 248.45 30.00 / 68.00
AMRUTAJAN HEALTH LTD 713.45 37.83 6.31 2062.63 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9221.25 109.01 29.92 23053.13 6222.35 / 10653.05
BLISS GVS PHARMA LTD 153.00 22.87 1.52 1615.83 105.05 / 190.65

SANJIVANI PARANTERAL LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
228.90 4.09 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 226.90
  • 26 Days 234.40
  • 10 Days 231.70
  • 50 Days 233.10
  • 12 Days 232.70
  • 100 Days 236.50
  • 20 Days 234.40
  • 200 Days 244.00
221.93 PIVOT

First Support

215.97

First Resistance

225.87

Second Support

212.03

Second Resistance

231.83

Third Support

206.07

Third Resistance

235.77

RSI

37.38

ADX

12.00

MACD

-1.69

Williams % R

-95.87

Commodity Channel Index (CCI)

-174.90

Date

2025-10-01

Week

3015.00

Same Day

1675.00

Month

5315.00

1 Year

0.85

3 Year

0.73

Over 1 Month

-12.87%

down

Over 1 Year

-30.41%

down

Over 3 Months

1.10%

down

Over 3 Years

62.54%

down

Over 6 Months

-11.47%

down

Over 5 Years

88.21%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

SANJIVANI PARANTERAL LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
62.76%
Promoter Holdings
31.2%
FII
0.0%
DII
6.02%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Ashwani Khemka 3625651.0 (29.51%) Shareholding of Promoter and Promoter Group
Suresh Pukhraj Jain . 821100.0 (6.68%) Public Shareholding
Kanta Suresh Jain . 741693.0 (6.04%) Public Shareholding
India Equity Fund 1 609866.0 (4.96%) Public Shareholding
Sun Capital Advisory Services Private Limited 500000.0 (4.07%) Public Shareholding
Ashish Kacholia 370000.0 (3.01%) Public Shareholding
Usha Ravindra Bhat 267000.0 (2.17%) Public Shareholding
Naina Khemka 207410.0 (1.69%) Shareholding of Promoter and Promoter Group
Next Orbit Ventures Fund 130802.0 (1.06%) Public Shareholding

News

Left Arrow
Right Arrow

SANJIVANI PARANTERAL LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2025 0.5 Final 19 Sep 2025 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

SANJIVANI PARANTERAL LTD. Share Price

Sanjivani Paranteral Ltd is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades. The Company primarily focus on life-saving drugs and has exports to over 25 countries, while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun.

Incorporated as a public limited company in Oct.'94, Sanjivani Parenteral was jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry. The Company has been involved in the manufacturing of pharmaceutical medicines. The Company's products includes oral solids, small volume parenteral and sterile powder formulations.

The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade anti-biotics and life saving injectibles used in various infections, pre- and post-operative. The installed capacities for its products will be, 150 lac pa each for liquid vials and powder vials and 73 lac pa for its ampoules, taking the total capacity to 375 lac pa. The company came out with a public issue in Jan.'96 to part-finance the project.

The promoters have received firm inquiries from reputed pharmaceutical companies like Merind, Lupin Laboratories and USV for the first year' production of liquid vials and ampules.

During the year 1998-99, the Company has been approved by the WHO GMP Certificate. The Company is hoping for export of its products in Africa, Europe & Latin America. The Company has also tied up with Cadila Ltd., Alkem Ltd., Indian Immunologicals Ltd for marketing its products.

During the year 1999-2000, the company has tied-up with India's first ranked pharmaceutical giant Ranbaxy for manufacturing its products.

During 2009, the Company acquired a new pharmaceutical manufacturing plant in Uttarakhand.

Parent organization Indian Private
NSE symbol [-]
Founded 1994
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Sanjivani Paranteral Ltd?

Answer Field

Sanjivani Paranteral Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 228.90 as on Oct 03 2025 02:12 PM.

What is the Market Cap of Sanjivani Paranteral Ltd Share?

Answer Field

The market cap of Sanjivani Paranteral Ltd for NSE ₹ 0.00 & for BSE ₹ 281.20 as on Oct 03 2025 02:12 PM.

What is the 52 Week High and Low of Sanjivani Paranteral Ltd?

Answer Field

The 52 Week High and Low of Sanjivani Paranteral Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 396.95 and ₹ 203.10.

What is 1 year return for Sanjivani Paranteral Ltd?

Answer Field

The 1 year returns on the stock has been -30.41%.

What is the P/E Ratio of Sanjivani Paranteral Ltd Share?

Answer Field

As on Oct 03 2025 02:12 PM the price-to-earnings (PE) ratio for Sanjivani Paranteral Ltd share is 33.27.

What is the PB ratio of Sanjivani Paranteral Ltd Share?

Answer Field

As on Oct 03 2025 02:12 PM, the price-to-book (PB) ratio for Sanjivani Paranteral Ltd share is 34.25.

How to Buy Sanjivani Paranteral Ltd Share?

Answer Field

You can trade in Sanjivani Paranteral Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sanjivani Paranteral Ltd Share on Bajaj Broking App?

Answer Field

To buy Sanjivani Paranteral Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sanjivani Paranteral Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91